Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Karen Jean Chayt Marcus, M.D.

Co-Author

This page shows the publications co-authored by Karen Marcus and Nancy Tarbell.
Connection Strength

2.171
  1. Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. Int J Radiat Oncol Biol Phys. 2005 Feb 01; 61(2):374-9.
    View in: PubMed
    Score: 0.312
  2. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys. 2003 Apr 01; 55(5):1182-5.
    View in: PubMed
    Score: 0.274
  3. Childhood soft tissue sarcoma: a 20-year experience. J Pediatr. 1997 Oct; 131(4):603-7.
    View in: PubMed
    Score: 0.187
  4. The Changing Role of Radiation Therapy in the Treatment of Neuroblastoma. Semin Radiat Oncol. 1997 Jul; 7(3):195-203.
    View in: PubMed
    Score: 0.184
  5. Proton beam therapy for medulloblastoma - Author's reply. Lancet Oncol. 2016 05; 17(5):e174-5.
    View in: PubMed
    Score: 0.170
  6. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Mar; 17(3):287-298.
    View in: PubMed
    Score: 0.167
  7. Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers. Int J Oncol. 2007 Mar; 30(3):651-7.
    View in: PubMed
    Score: 0.090
  8. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1208-14.
    View in: PubMed
    Score: 0.073
  9. Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma. J Clin Oncol. 2019 12 10; 37(35):3335-3339.
    View in: PubMed
    Score: 0.054
  10. Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018. Int J Radiat Oncol Biol Phys. 2019 Apr 01; 103(5):1026-1030.
    View in: PubMed
    Score: 0.052
  11. Larry Emanuel Kun, March 10, 1946-May 27, 2018. Int J Radiat Oncol Biol Phys. 2019 Jan 01; 103(1):8-14.
    View in: PubMed
    Score: 0.051
  12. Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome. Blood. 1996 May 01; 87(9):3625-32.
    View in: PubMed
    Score: 0.042
  13. Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer. 2015 Sep; 62(9):1523-8.
    View in: PubMed
    Score: 0.039
  14. Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol. 2014 Nov 20; 32(33):3762-70.
    View in: PubMed
    Score: 0.038
  15. Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: a report from the Children's Oncology Group. Cancer. 2015 Feb 01; 121(3):467-75.
    View in: PubMed
    Score: 0.038
  16. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014 Aug 01; 89(5):1060-1068.
    View in: PubMed
    Score: 0.037
  17. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro Oncol. 2013 Nov; 15(11):1552-9.
    View in: PubMed
    Score: 0.036
  18. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 2014 Jan 01; 120(1):126-33.
    View in: PubMed
    Score: 0.036
  19. Association between radiotherapy vs no radiotherapy based on early response to VAMP chemotherapy and survival among children with favorable-risk Hodgkin lymphoma. JAMA. 2012 Jun 27; 307(24):2609-16.
    View in: PubMed
    Score: 0.033
  20. Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1142-8.
    View in: PubMed
    Score: 0.031
  21. Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):34-40.
    View in: PubMed
    Score: 0.025
  22. Changes in cerebral cortex of children treated for medulloblastoma. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):992-8.
    View in: PubMed
    Score: 0.023
  23. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology. 2007 Mar 20; 68(12):932-8.
    View in: PubMed
    Score: 0.023
  24. Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin's disease. J Clin Oncol. 2007 Jan 20; 25(3):332-7.
    View in: PubMed
    Score: 0.022
  25. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol. 2004 Nov 15; 22(22):4541-50.
    View in: PubMed
    Score: 0.019
  26. Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg. 2003 Oct; 238(4):563-7; discussion 567-8.
    View in: PubMed
    Score: 0.018
  27. Prognostic factors for children with Hodgkin's disease treated with combined-modality therapy. J Clin Oncol. 2003 May 15; 21(10):2026-33.
    View in: PubMed
    Score: 0.017
  28. Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors. Blood. 2002 Sep 15; 100(6):1989-96.
    View in: PubMed
    Score: 0.017
  29. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial. J Clin Oncol. 2002 Jul 15; 20(14):3081-7.
    View in: PubMed
    Score: 0.016
  30. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol. 2002 Apr 15; 20(8):2101-8.
    View in: PubMed
    Score: 0.016
  31. Low-dose total body irradiation and G-CSF without hematopoietic stem cell support in the treatment of relapsed or refractory acute myelogenous leukemia (AML), or AML in second or subsequent remission. Int J Radiat Oncol Biol Phys. 1998 Dec 01; 42(5):1113-7.
    View in: PubMed
    Score: 0.013
  32. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease. Cancer J Sci Am. 1995 May-Jun; 1(1):33-42.
    View in: PubMed
    Score: 0.010
  33. Prognostic factors for patients with Hodgkin disease in first relapse. Cancer. 1993 Apr 15; 71(8):2613-20.
    View in: PubMed
    Score: 0.009
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.